Related Experiment Videos
Intravesical dimethyl sulfoxide (DMSO) for interstitial cystitis--a practical approach
1Interstitial Cystitis Clinic, New England Medical Center, Boston, MA 02111, USA.
Urology
|May 1, 1997
Summary
Intravesical dimethyl sulfoxide (DMSO) therapy offers a safe and effective treatment option for interstitial cystitis. This approach helps a significant number of patients manage their condition with minimal side effects.
Area of Science:
- Urology
- Pharmacology
Background:
- Interstitial cystitis (IC) is a chronic condition causing bladder pain and urinary urgency.
- Current treatment options for IC can be limited, necessitating exploration of effective therapies.
Purpose of the Study:
- To review intravesical dimethyl sulfoxide (DMSO) therapy for interstitial cystitis.
- To present a practical treatment approach for patients with IC receiving DMSO.
Main Methods:
- Literature review on intravesical DMSO for IC.
- Analysis of treatment experience with over 300 IC patients using DMSO.
Main Results:
- Intravesical DMSO demonstrates efficacy in a substantial proportion of IC patients.
- The treatment exhibits acceptable morbidity and a favorable safety profile.
Conclusions:
- Intravesical DMSO is a cornerstone pharmacologic treatment for interstitial cystitis.
- DMSO can be used as a single agent or in combination therapies for IC management.